Skip to main content

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in ABVX — Abivax S.A.

CIK 1446194 BALA CYNWYD, PA

Position in ABVX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$140,442,180
+$97,986,430 QoQ
Shares Held
1,053,896
+176.4% QoQ
Ownership
1.21%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#14
of 302 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ABVX Over Time

Shares Held

Position Value (USD)

Derivatives in ABVX

reported options exposure · as of Jun 30, 2026
CallValue
$327,659,688
CallShares
2,458,800
PutValue
$151,276,752
PutShares
1,135,200

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,650,012,247 across 349 Biotechnology names. ABVX ranks #1 (8.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABVX
Abivax S.A.
This page
1,053,896 $140,442,180

All Filings in ABVX

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $327,659,688 2,458,800
2026-06-30 $140,442,180 1,053,896
2026-06-30 $151,276,752 1,135,200
2026-03-31 $42,455,750 381,282
2026-03-31 $42,045,760 377,600
2026-03-31 $58,558,965 525,900
2025-12-31 $55,155,695 409,000
2025-12-31 $101,793,408 754,836
2025-12-31 $43,800,904 324,800
2025-09-30 $2,938,728 34,614
2025-09-30 $2,903,580 34,200
2025-09-30 $3,837,480 45,200